Cantor downgraded Pernix Therapeutics to Sell with a $2.50 price target citing weak prescription trends and the 1.25M share sale by former CEO Cooper Collins ahead of the Q2 results.
Am I alone in wondering why Cantor downgraded this stock to sell after the run up to over $4.00 yesterday?
I think we all know this will proabably be their worst quarter to date. Cantor trying to get ahead of the game, and the CEO sale is disturbing to say the least
Why does Cantor care about a no name company like PTX is beyond me.. just another SAC Capt type of strategy in progress..
Cantor is destroying any hope for PTX.. HUGE % DUMP!.... thx prix!
The SOMX nightmare continues with no light at the end of the tunnel.. what a mess for so long!